| Teriparatide biosimilar (Biosidus) |
rhPTH (1-34) (Biosidus) |
Approved |
Biosidus |
Osteofortil |
Ecuador |
Osteoporosis |
s:8:"Biosidus"; |
2012-08-01 |
Osteoporosis |
Details
|
| Teriparatide biosimilar (Zydus Cadila) |
rhPTH (1-34) (Zydus Cadila) |
Approved |
Zydus Cadila |
|
India |
Osteoporosis |
s:12:"Zydus Cadila"; |
2014-01-01 |
Osteoporosis |
Details
|
| Teriparatide biosimilar (STADA Arzneimittel AG) |
rhPTH (1-34) (STADA Arzneimittel AG) |
Approved |
Stada Arzneimittel Ag |
Movymia |
EU |
Osteoporosis |
s:21:"Stada Arzneimittel Ag"; |
2017-01-11 |
Osteoporosis |
Details
|
| Teriparatide biosimilar (Gedeon Richter) |
rhPTH (1-34) (Gedeon Richter) |
Approved |
Gedeon Richter Plc |
Terrosa |
EU |
Osteoporosis |
s:18:"Gedeon Richter Plc"; |
2017-01-04 |
Osteoporosis |
Details
|
| Teriparatide biosimilar (Salubris) |
|
Approved |
Shenzhen Salubris Pharmaceuticals Co Ltd |
欣复泰 |
Mainland China |
Osteoporosis, Postmenopausal |
s:29:"Suzhou Genemen Biotech Co Ltd"; |
2019-09-29 |
Osteoporosis, Postmenopausal |
Details
|
| Recombinant Teriparatide（Shanghai United Cell ） |
|
Approved |
Shanghai United Cell Biotechnology Co Ltd |
|
Mainland China |
Osteoporosis |
s:41:"Shanghai United Cell Biotechnology Co Ltd"; |
2017-03-22 |
Osteoporosis |
Details
|
| Teriparatide acetate |
AK-159; MN-10-T; hPTH (1-34) acet. H2O |
Approved |
Union Square Ventures Llc |
Parathar, Teribone |
Japan |
Osteoporosis; Hypocalcemia |
s:4:"null"; |
1987-03-31 |
Osteoporosis; Hypocalcemia |
Details
|
| Abaloparatide |
BA-058; ITM-058; BA-058-SC; BA-058-TD; BIM-44058 |
Approved |
Ipsen |
Tymlos |
United States |
Osteoporosis, Postmenopausal |
s:17:"Radius Health Inc"; |
2017-04-28 |
Osteoporotic Fractures; Osteoporosis; Osteoporosis, Postmenopausal |
Details
|
| Teriparatide biosimilar (USV) |
|
Approved |
Usv |
|
|
|
N; |
|
Osteoporosis |
Details
|
| Teriparatide biosimilar (Virchow/Sun) |
rhPTH (1-34) (Virchow/Sun) |
Approved |
Virchow Group, Sun Pharmaceutical |
Bonista, Osteotide |
|
|
N; |
|
Osteoporosis |
Details
|
| Teriparatide biosimilar (Intas Pharmaceuticals) |
rhPTH (1-34) (Intas Pharmaceuticals) |
Approved |
Intas Biopharmaceuticals |
Terifrac |
India |
Osteoporosis |
s:24:"Intas Biopharmaceuticals"; |
2010-12-01 |
Osteoporosis |
Details
|
| Teriparatide (Amega Biotech) |
rhPTH (1-34) (Amega Biotech) |
Approved |
Amega Biotech |
|
|
|
N; |
|
Osteoporosis |
Details
|
| Teriparatide biosimilar (CinnaGen) |
rhPTH (1-34) (CinnaGen) |
Approved |
Cinnagen |
CinnoPar |
Iran |
Osteoporosis |
s:8:"Cinnagen"; |
2013-01-01 |
Osteoporosis |
Details
|
| Teriparatide biosimilar (Theramex) |
|
Approved |
Theramex Ireland Ltd |
Livogiva |
EU |
Osteoporosis |
s:20:"Theramex Ireland Ltd"; |
2020-08-27 |
Osteoporosis |
Details
|
| Teriparatide biosimilar (Pfenex) |
rhPTH (1-34) (Pfenex); PF-708 |
Approved |
Pfenex |
Qutavina, Bonsity |
United States |
Osteoporosis |
s:7:"Alvogen"; |
2019-10-04 |
Osteoporosis |
Details
|
| Parathyroid hormone (Shire) |
423562; ALX-111; SHP-634; SHP-635; NPSP-558; NPSP-795; PTH 1-84; SB-423562; PTH (1-84); rhPTH-1-84; rhPTH (1-84) |
Approved |
Shire |
Natpar, Natpara, Preotact |
EU |
Hypoparathyroidism |
s:33:"Shire Pharmaceuticals Ireland Ltd"; |
2006-04-24 |
Osteoporosis; Osteoporosis, Postmenopausal; Hypoparathyroidism |
Details
|
| Teriparatide |
LY 333334; MN-10T; hPTH-1-34 |
Approved |
Eli Lilly And Company |
复泰奥, Forteo, Forsteo |
Mainland China |
Osteoporosis; Osteoporosis, Postmenopausal |
s:22:"Eli Lilly Nederland Bv"; |
2002-11-26 |
Osteoporotic Fractures; Drug-Related Side Effects and Adverse Reactions; Osteoporosis; Bone Diseases, Metabolic; Osteoporosis, Postmenopausal; Colles' Fracture; Femoral Neck Fractures; Back Pain; Spinal Fractures; Hypoparathyroidism |
Details
|
A-Z